HS2
vs
CAH
HS2
CAH
Over the past 12 months, HS2 has underperformed CAH, delivering a return of -17% compared to the CAH's +79% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
HS2
CAH
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Henry Schein Inc
F:HS2
|
63.6
EUR
|
|||||
|
Cardinal Health Inc
NYSE:CAH
|
228.3
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
HS2, CAH
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Henry Schein Inc
Revenue
|
|||||||||||
|
Cardinal Health Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
HS2, CAH
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Henry Schein Inc
F:HS2
|
|||||||||
|
Cardinal Health Inc
NYSE:CAH
|
|||||||||
Compare company's free cash flow with its competitors.
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
HS2, CAH
Performance Gap
HS2, CAH
Performance By Year
HS2, CAH
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Mckesson Corp
NYSE:MCK
|
|
| US |
|
Cencora Inc
NYSE:COR
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
|
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|